Calidi Biotherapeutics, Inc.CLDINYSE
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
Year-over-Year Change
Price-to-earnings ratio
Latest
-0.41
↑ 100% vs avg
Percentile
P100
Near historical high
Streak
4 yr
Consecutive growthElevated
Average
-94.20
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2024 | -0.41 | +50.1% |
| 2023 | -0.83 | +75.5% |
| 2022 | -3.39 | +86.8% |
| 2021 | -25.69 | +94.2% |
| 2020 | -440.67 | - |